Inovio secures FDA nod for phase 2 segment of Covid-19 DNA vaccine candidate trial

Inovio has secured FDA approval for phase 2 segment of Covid-19 DNA vaccine candidate trial. (Credit: Gedesby1989 from Pixabay)